Reumofan Tablets Recalled after Reports of Stroke and Death

Drug recall attorneys at Pintas & Mullins Law Firm report that Reumofan and Reumofan Plus USA have announced the voluntary recall of Reumofan Plus Tablets because they contain numerous undeclared pharmaceutical ingredients. Among these ingredients include Methocarbamol, Dexamethasone, and Diclofenac.

Reumofan Tablets are marketed for use in those with muscle pain, arthritis, bone cancer, and osteoporosis, among other conditions. The “natural supplements” were sold in 30-tablet containers in green and gold boxes, primarily found online. Dietary supplements, such as those manufactured by Reumofan, are not subject to the same FDA regulations as prescription drugs, and are often tainted with dangerous ingredients.

Reumofan Tablets are manufactured by Riger Naturals in Mexico and sold in the US by Samantha Lynn Inc. The first safety alert the FDA released on these drugs was in June 2012, warning the public about reports of stroke, severe bleeding, problems with liver and kidney function, high blood sugar levels, corticosteroid withdrawal syndrome, and even death.

The unlisted ingredients in Reumofan Plus include Diclofenac Sodium, which is a prescription anti-inflammatory drug that is known to cause increase risk of stroke, heart attack, and gastrointestinal bleeding, ulceration, and fatal perforation of the stomach and intestines. The second unlisted ingredient, Methocarbomol, is a prescription muscle relaxer that causes low blood pressure, impaired mental and physical abilities, sedation, and dizziness. Dexamethasone, the third undeclared ingredient, is an anti-inflammatory and immune system suppressant.

Other adverse reports include weight gain, adrenal suppression, and worsening of glucose control. Anyone who is currently or has recently stopped taking Reumofan Plus Tablets are urged to consult a healthcare professional as soon as possible, stop taking the tablets, and return or dispose of them.

In related news, the FDA and U.S. Marshals recently raided the Florida pharmaceutical company Globe All Wellness, seizing supplies of many dietary drugs because they contained dangerous undeclared ingredients. The brand-name drugs that were seized include SlimXtreme, SlimXtreme Gold, SlimDrops, GelSlim, SlimPlus, SlimLee, and Colonew.

The raid was sparked by the company’s drug Meridia, a weight loss supplement that was withdrawn from the market in 2010. Meridia reportedly carried an excessive risk of adverse cardiovascular events, including heart attack and stroke. Both the FDA and the European Union banned Meridia, the brand-name for generic Sibutramine, from sales in October 2011, although the FDA warned that more than 20 other brands of diet drugs were tainted with Sibutramine.

Additionally, the dietary supplements Cataplex ACEP, Cataplex C, and Pancreatrophin PMG were withdrawn from the market in 2012 for potential salmonella contamination. These products were marketed as multi-vitamins in minerals to bridge nutritional gaps in the diet.

Companies that knowingly manufacture and distribute drugs with undeclared pharmaceutical ingredients are not only breaking the law, but are putting unsuspecting consumers at extreme risk. This is why experts and officials warn against consuming products marketed as supplements claiming to have any of the same effects as prescription drugs. They also say to avoid purchasing any products in which the labeling information is written only in a foreign language. Reumofan Plus Tablets labels, for example, appeared only in Spanish.

Drug recall lawyers at Pintas & Mullins Law Firm warn the public about dietary supplements that claim to be “all natural” while still claiming to have the same effects as prescription drugs. Many of these products contain dangerous ingredients that are not disclosed on the label, and can cause serious, life-threatening reactions. If you or someone you love was serious affected by dietary supplements, you may be entitled to compensation, and should seek the guidance of an experienced attorney.

Categories

Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.